Thursday, July 17, 2025 7/17/2025

Establish a Public Private Partnership for COVID19 Research

Award Number: OT2OD030195
ORGANIZATION: OFFICE OF THE DIRECTOR, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: OTHER
PERIOD OF PERFORMANCE START DATE: 05/02/2020
PERIOD OF PERFORMANCE END DATE: 02/29/2024

Group Awards By:

View Award Description

Establish a Public Private Partnership for COVID19 Research - The Foundation for the National Institutes of Health (FNIH) (www.fnih.org) was chartered by the Congress of the United States in 1990 as a not-for-profit 501(c)(3) charitable organization and has been working to facilitate groundbreaking research at the National Institutes of Health (NIH) and worldwide since 1996, creating and managing numerous biomedical public-private research partnerships that support the NIH’s mission. The FNIH therefore has extensive experience working with both NIH and the biopharmaceutical industry and deep familiarity with NIH’s people, science, practices, and policies. The FNIH has been asked by Dr. Francis S. Collins, Director of the NIH, to assist the agency in its response to the COVID-19 crisis. The aim of this collaboration is to accelerate NIH research urgently required to respond to this public health threat and to save lives by leveraging private-sector scientific expertise, in-kind assets and financial resources to augment federal efforts. Dr. Collins’ request that the FNIH help create a COVID-19 public-private partnership (PPP) to accelerate the development of therapeutics and vaccines under the Accelerating Medicines Partnership (AMP) is consistent with the FNIH’s own mission and the Congressional statute by which the FNIH was established to support the NIH in its mission and to advance collaboration with biomedical researchers from universities, industry, nonprofit organizations and other federal agencies, including the US Food and Drug Administration (FDA). AMP is a nimble and powerful public-private partnership that includes the NIH, FNIH, FDA and multiple biopharmaceutical companies and not-for-profit organizations. Managed by the FNIH, AMP programs bring together the resources of the NIH and industry to improve our understanding of disease pathways and facilitate better selection of targets for treatment. Multimillion dollar collaborations supported by the private sector through the FNIH have been established in four major disease areas: Alzheimer's disease, Type 2 diabetes, Rheumatoid Arthritis (RA)/Lupus and Parkinson's disease. The FNIH is also preparing to launch an AMP in Schizophrenia in partnership with the National Institute on Mental Health (NIMH). The overarching goal of the FNIH in this new AMP is to support the NIH in designing and implementing a strategic and coordinated cross-sector approach to end the current COVID-19 pandemic and to manage future such threats. This PPP is now known as ACTIV, the Accelerated COVID-19 Therapeutic Intervention and Vaccine partnership. Notably, most AMP projects start with a Design Phase that takes approximately 9 months to complete in which the FNIH identifies key partners, establishes scientific working and sub-groups, puts in place governance structures, executes contracts and agreements, deploys and trains appropriate staff, and identifies potential sources of funding. The result of the Design Phase is a detailed scientific and business plan for the PPP, which is called the Implementation Plan (sometimes referred to as the White Paper). The resulting Implementation Phase is a multiyear effort in which the PPP, through management by the FNIH, operationalizes the scientific plan and coordinates this work with critical support provided by NIH using its grants and contracts mechanisms. However, given the acute public health threat that has resulted in tens of thousands of COVID-19 deaths, the FNIH responded immediately to NIH’s call to action, redirecting staff from active, fully funded donor-supported programs to begin work on the Design Phase for the proposed PPP even though no financing for the FNIH’s work has yet been secured. In fact, for the past four weeks, the FNIH staff has been working non-stop on ACTIV, including nights and weekends, and has already achieved in record time what under normal circumstances would have taken months. This redeployment of staff is not sustainable, and the resulting costs and lost revenue are imposing a


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$554,757 )
2025	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	000	1	10/28/2024	SUPPLEMENT FOR EXPANSION	-$554,757
														Subtotal = -$554,757

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	001	1	12/21/2023	SUPPLEMENT FOR EXPANSION	$0
2024	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	000	1	12/20/2023	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $2,838,787 )
2023	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	002	1	5/3/2023	SUPPLEMENT FOR EXPANSION	$0
2023	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	004	1	5/26/2023	SUPPLEMENT FOR EXPANSION	$1,181,709
2023	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	005	1	7/31/2023	SUPPLEMENT FOR EXPANSION	$598,668
2023	2023	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	000	1	1/13/2023	SUPPLEMENT FOR EXPANSION	$1,058,410
2023	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	003	1	5/25/2023	NEW	$0
2023	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	001	1	5/2/2023	NEW	$0
														Subtotal = $2,838,787

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	003	1	7/5/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	000	1	12/14/2021	SUPPLEMENT FOR EXPANSION	$0
2022	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	002	1	7/1/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	001	1	12/14/2021	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $7,347,904 )
2021	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	005	1	7/1/2021	SUPPLEMENT FOR EXPANSION	$1,250,000
2021	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	004	1	6/30/2021	SUPPLEMENT FOR EXPANSION	$199,770
2021	2021	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	002	1	1/29/2021	SUPPLEMENT FOR EXPANSION	$5,898,134
2021	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	003	1	6/29/2021	NEW	$0
2021	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	000	1	12/16/2020	NEW	$0
2021	2020	FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.	11400 ROCKVILLE PIKE STE 600	NORTH BETHESDA	MD	20852	MONTGOMERY	USA	Trans-NIH Research Support	001	1	12/17/2020	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $7,347,904

Grand Total All Awards = $9,631,934

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Establish a Public Private Partnership for COVID19 Research

Award Number: OT2OD030195

ORGANIZATION: OFFICE OF THE DIRECTOR, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: OTHER

PERIOD OF PERFORMANCE START DATE: 05/02/2020

PERIOD OF PERFORMANCE END DATE: 02/29/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer